Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2013

Aug 16, 2013

34519_dirs_2013-08-16_5b810afc-1d86-4275-ae26-917f40e36d93.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2013-08-14

Reporting Person: Cunningham David (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-08-14 Common Stock, par value $0.10 per share P 162 $3.6 Acquired 162 Direct
2013-08-14 Common Stock, par value $0.10 per share P 38 $3.6 Acquired 200 Direct
2013-08-14 Common Stock, par value $0.10 per share P 100 $3.6 Acquired 300 Direct
2013-08-14 Common Stock, par value $0.10 per share P 62 $3.65 Acquired 362 Direct
2013-08-14 Common Stock, par value $0.10 per share P 500 $3.65 Acquired 862 Direct
2013-08-14 Common Stock, par value $0.10 per share P 100 $3.65 Acquired 962 Direct
2013-08-14 Common Stock, par value $0.10 per share P 38 $3.65 Acquired 1000 Direct
2013-08-15 Common Stock, par value $0.10 per share P 1000 $3.7 Acquired 2000 Direct
2013-08-15 Common Stock, par value $0.10 per share P 1000 $3.7 Acquired 3000 Direct
2013-08-16 Common Stock, par value $0.10 per share P 36 $3.7 Acquired 3036 Direct
2013-08-16 Common Stock, par value $0.10 per share P 100 $3.69 Acquired 3136 Direct
2013-08-16 Common Stock, par value $0.10 per share P 100 $3.7 Acquired 3236 Direct
2013-08-16 Common Stock, par value $0.10 per share P 764 $3.7 Acquired 4000 Direct

Footnotes

F1: These shares are beneficially owned by the Cunningham Family Revocable Trust, of which Mr. Cunningham is a beneficiary.